WuXi Biologics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.11.23	WuXi Biologics Receives AAA MSCI ESG Rating (PR Newswire)
17.10.23	WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality (PR Newswire)
02.10.23	WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease (PR Newswire)
22.05.23	WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations (PR Newswire)
28.04.23	WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability (PR Newswire)
28.03.23	WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease (PR Newswire)
05.01.23	WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers (PR Newswire)
16.12.22	WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List (PR Newswire)
12.10.22	WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody (PR Newswire)
10.10.22	WuXi Biologics Co., Ltd. Removed from Unverified List (PR Newswire)
29.09.22	WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility in Worcester, Massachusetts (PR Newswire)
20.09.22	WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA (PR Newswire)
19.07.22	WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore (PR Newswire)
06.06.22	WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes (PR Newswire)
28.04.22	WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability (PR Newswire)
08.02.22	WuXi Biologics Statement (PR Newswire)
01.11.21	WuXi Biologics Launches a New GMP Commercial Drug Product Facility (PR Newswire)
02.08.21	WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate (PR Newswire)
02.08.21	WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate (PR Newswire)
02.08.21	WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate (PR Newswire)
27.07.21	WuXi Biologics erhält von den deutschen Gesundheitsbehörden die Lizenz zur kommerziellen Herstellung von Arzneimitteln in Deutschland (PR Newswire)
26.07.21	WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility (PR Newswire)
26.07.21	WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility (PR Newswire)
26.07.21	WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility (PR Newswire)
10.06.21	WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates (PR Newswire)
10.06.21	WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu WuXi Biologics (Cayman) Inc. Unsponsored American Deposit Receipt Repr 2 Shs

Aktien Top/Flop

Meistgelesene Nachrichten